GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] SSA survo — Medutest came back 97.4% against a claimed 96.2% — 26 comments in the full submission. View in context.
737
c/compounding·submitted 2 years ago by u/chidi_demir

[Lab] SSA survo — Medutest came back 97.4% against a claimed 96.2%

Explainerbranch of 8 comments

Been lurking in c/trialwatch for about 10 months and finally have something worth posting. Short version: week 46, 0.5mg, and compounding is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 11 threads, and the answers split roughly down the middle. What I actually want to…

Read the full submission and all 26 comments →

This branch

8 comments, started 2 years ago
u/amara_kuipers97 points·2 years ago

The telehealth + compounding combo cost API source plus 11% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/zaid_grimaldi113 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/eu_apotheke_a77 points·2 years ago

What is the actual shortage list status right now?

replysharereportpermalink
u/chidi_demirOP49 points·2 years ago·edited

The telehealth + compounding combo cost 503A plus 3% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/marit_laurent88 points·2 years ago

Yeah, 503A and 503B are different regulatory animals.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/mateusz_adebayo73 points·2 years ago

shortage list status is telehealth, check the actual list

replysharereportpermalink
u/chidi_demirOP-9 points·2 years ago

Asked 23 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.

replysharereportpermalink
u/niels_roos1 point·2 years ago

the Poland situation is different from the US, different regulations

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →